Researchers call for more public disclosure about clinical drug trials
Publishing in the August 3 issue of the Annals of Internal Medicine, the researchers call for more public disclosure about clinical drug trials at their outset to reduce the possibility of bias in the findings.
To address such concerns, a report by the US Institute of Medicine released on Tuesday suggests that all payments by drug and medical devices companies to doctors, scientists and patient groups in the US be posted publicly online.